The anti-IgE antibody omalizumab reduced exacerbations and steroid requierement in allergic asthmatic. - Soler,M.; Matz,J.; Townley,R.; Buhl,R.; O'Brien,J.; Fox,H.; Thirlwell,J.; Related Articles Gupta,N.; Della Cioppa,G. (Eur Respir J, 2001)